Cargando…
IMT-02 VEGF RECEPTORS EXPRESSION AND REPORT OF CLINICAL TRIAL OF PEPTIDE VACCINE IN SKULL BASE CHORDOMA
Chordoma is a rare refractory neoplasm that arises from the embryological remnants of the notochord. Vascular endothelial growth factor (VEGF) is a potent activator of angiogenesis that is associated with the tumor-immune microenvironment. To evaluate the characteristics of vascular and tumor cells...
Autores principales: | Morimoto, Yukina, Toda, Masahiro, Tamura, Ryota, Ohara, Kentarou, Oishi, Yumiko, Yoshida, Kazunari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213404/ http://dx.doi.org/10.1093/noajnl/vdz039.077 |
Ejemplares similares
-
Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series
por: Tamura, Ryota, et al.
Publicado: (2020) -
Correction to: Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series
por: Tamura, Ryota, et al.
Publicado: (2020) -
Long-Term Clinical Outcome of First Recurrence Skull Base Meningiomas
por: Kuranari, Yuki, et al.
Publicado: (2019) -
A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2
por: Tamura, Ryota, et al.
Publicado: (2019) -
Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2
por: Tamura, Ryota, et al.
Publicado: (2020)